Efficacy of Tc-99m depreotide scintigraphy in the evaluation of solitary pulmonary nodules

Cancer Journal

Volumn 8, Issue 5, 2002, Pages 400-404

  Grewal, Ravinder K ^a   Dadparvar, Simin ^a   Yu, Jian Q ^a   Babaria, Chatur J ^a   Cavanaugh, Thomas ^a   Sherman, Michael ^a   Jacobstein, Jerome ^a  

^a HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

Comparative study; CT imaging; Follow up; Human; Primary lung carcinoma; Single pulmonary nodule; Tc 99m depreotide scintigraphy

Indexed keywords

DEPREOTIDE TC 99M; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN; TECHNETIUM COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PREDICTION; PRIORITY JOURNAL; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX; BIOPSY; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; LUNG COIN LESION; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; COIN LESION, PULMONARY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0036731395     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200209000-00011     Document Type: Article

References (24)

1. Berman CG, Clark RA. Positron emission tomography in initial staging and diagnosis of persistent or recurrent disease. Curr Opin Oncology 2000;12:132-137.
2. Blum J, Handmaker H, Lister-James J et al. A multicenter trial with a somatostatin analog 99m Tc depreotide in the evaluation of solitary pulmonary nodules. Chest 2000;117:1232-1238,
3. Liu BQ, Peto R, Chen ZM et al. Emerging tobacco hazards in China: I. Retrospective proportional mortality study of one million deaths. BMJ 1998;317:1411-1422.
4. Weiss W. Cigarette smoking and lung cancer trends: a light at the end of the tunnel? Chest 1997;111:1414-1416.
5. Read C. Coin lesion, pulmonary: in the Southwest. Arizona Med 1972;29:775-781.
6. Siegelman SS, Khouri NF, Leo FP et al. Solitary pulmonary nodules: CT assessment. Radiology 1986;160:307-312.
7. Lillington GA, Gould MK. Managing solitary pulmonary nodules: accurate predictions and divergent conclusions. Mayo Clin Proc 1999;74:435-436.
8. Goldsmith SJ, Kostakoglu L. Role of nuclear medicine in the evaluation of the solitary pulmonary nodule. Semin Ultrasound CT and MRI 2000;21:129-138.
9. NeoTecT package insert. Rentscler Biotechnologie GmbH&Co. KG, Laupheim, Germany, for Diatide, Inc., Londonderry, New Hampshire.
10. Lamberts SWJ, Van der Lely AJ, de Herder WW et al. Octreotide. N Engl J Med 1996;34:246-254.
11. Menda Y, Kahn D. Somatostatin receptor imaging of non small cell lung cancer with 99m Tc depreotide. Semin Nucl Med 2002;32;92-96.
12. Vallabhajosula S, Moyer B, Lister-James J et al. Preclinical evaluation of technetium 99m labeled somatostatin receptor-binding peptides. J Nucl Med 1996;37:1016-1022.
13. Lister-James J, McBride WJ, Moyer BR et al. A structure-activity-relationship study of somatostatin receptor binding peptides radiolabelled with Tc- 99m. J Nucl Med 1994;35:257P.
14. Fujita T, Yamaji Y, Sato M et al. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR2, in human lung cancer cell lines. Life Sci 1994;55:1797-1806.
15. Oyen WJG, Boerman OC, Claessens RAMJ et al. Is somatostatin receptor scintigraphy suited to detection of acute infectious disease? Nucl Med Commun 1994; 15:289-293.
16. Berkowitz M, Waxman AD. The utility of Neotect in evaluation of pulmonary malignancy [abstract].J Nucl Med 2001;42:28P.
17. tm) J Nucl Med 2001;42:304P.
18. Reisinger I, Bohuslavitzki KH, Brenner W et al. Somatostatin receptor scintigraphy in small cell lung cancer: results of a multicenter study. J Nucl Med 1998;39:224-227.
19. Abdel-Dayem HM, Scott A, Macapinlac H et al. Tracer imaging in lung cancer. Eur J Nucl Med 1994;21;57-81.
20. Coates G, Skehan SJ. Emerging role of PET in the diagnosing and staging of lung cancer. Can Respir J 1999,6:145-152.
21. Patz EF, Erasmus JJ. Positron emission tomography imaging in lung cancer. Clin Lung Cancer 1999;1:42-48.
22. Kernstine KH, Kahn D, Menda Y et al. A new technique for staging potentially resectable lung cancer: Neotect Spect Tc-99m (Neot) compared with F-18 FDG [poster]. American Society of Clinical Oncology Program/Proceedings Periodicals 2001:20:339a.
23. Bridwell RS, Rinne NA, Halkar RK et al. Managing the Solitary Pulmonary Nodule (SPN): A Multidisciplinary Approach. A CME Web Teleconference Series. April 9, 16, and 23, 2002.
24. Morehead RS, Shih WJ. Tc-99m-labelled somatostatin receptor-binding peptide imaging for a pulmonary nodule. Clin Nucl Med 2001;26:910-912.